Superdrolyn 10 Driada Medical EU

Methyldrostanolone (Superdrolyn 10 / Superdrol) - Driada Medical EU

The provided text details Methyldrostanolone, a potent oral anabolic steroid commonly known by the trade name Superdrol. It is manufactured by Driada Medical.

Note: Methyldrostanolone is an extremely powerful, hepatotoxic (liver-toxic) steroid that is banned by major sports organizations (WADA). Its use is associated with high risks.

Overview and Key Characteristics 

Methyldrostanolone is a highly potent, orally active derivative of Dihydrotestosterone (DHT).

• Extreme Potency: Superdrol is one of the most powerful oral steroids available, known for delivering rapid, dramatic gains in lean muscle mass and strength within a short period (often 2–4 weeks).

• Muscle Quality: Gains are typically hard and dry, as the compound does not aromatize (convert to estrogen). This means there is no water retention or estrogenic side effects like gynecomastia.

• Fast Action: Due to its oral nature and short half-life, its effects are felt very quickly.

• Dosage: The concentration is $10 \text{ mg}/\text{tab}$. Typical dosage ranges for experienced users are very low, often between $10\text{ mg}$ and $30\text{ mg}$ per day.

Usage and Protocol (Common Illicit Use) 

• Duration: Cycles are typically very short, usually 4 weeks, max 6 weeks, due to its severe liver toxicity.

• Liver Support: Liver protection (such as TUDCA or NAC) is considered absolutely mandatory for the entire cycle and several weeks afterward.

• PCT: Post-Cycle Therapy (PCT) is essential due to the severe suppression of natural testosterone caused by the drug.

Side Effects and Risks 

Superdrol is famous for both its effectiveness and its harshness on the body:

• Severe Hepatotoxicity (Liver Toxicity): This is the most significant risk. It is one of the most hepatotoxic oral steroids and has been linked to numerous cases of severe liver damage and failure.

• Cardiovascular Strain: It causes severe, rapid, and negative changes to the lipid profile (drastic reduction in HDL and increase in LDL cholesterol), posing a major cardiovascular risk.

• Androgenic Effects: Being a DHT derivative, it carries risks of androgenic side effects such as acne, accelerated hair loss (if prone to male pattern baldness), and temporary suppression of natural testosterone.

• Other Side Effects: Extreme fatigue/lethargy, severe back/shin pumps (due to mineral depletion), and joint pain are common.

 Frequently Asked Questions (FAQ)

1. What is the most severe health risk associated with Methyldrostanolone (Superdrol) use?

The most severe health risk is severe hepatotoxicity (liver toxicity). Because it is a C-17 alpha-alkylated compound, Superdrol is metabolized very slowly by the liver, placing extreme stress on the organ.

2. Why is Superdrol typically used for cycles of only 4 to 6 weeks?

The cycle length is severely restricted to 4 to 6 weeks due to the drug's intense liver toxicity. Prolonged use drastically increases the risk of permanent liver damage or failure.

3. Does Superdrol cause gynecomastia or water retention?

No. Methyldrostanolone is a DHT derivative and does not aromatize (convert to estrogen). Therefore, it does not cause water retention or gynecomastia through the estrogenic pathway.

4. What is the biggest non-liver related side effect of Superdrol?

The biggest non-liver related risk is the severe negative impact on the cardiovascular lipid profile (drastic lowering of protective HDL cholesterol), which significantly increases the risk of heart disease.